Noris M, Remuzzi G (2005) Hemolytic uremic syndrome. J Am Soc Nephrol 16: 1035–1050.
[2]
Caprioli J, Noris M, Brioschi S, Pianetti G, Castelletti F, et al. (2006) Genetics of HUS: The impact of MCP, CFH and IF mutations on clinical presentation, response to treatment and outcome. Blood 108: 1267–1279.
[3]
Richards A, Buddles MR, Donne RL, Kaplan BS, Kirk E, et al. (2001) Factor H mutations in haemolytic uremic syndrome cluster in exons 18–20, a domain important for host cell recognition. Am J Hum Genet 68: 485–490.
[4]
Fremeaux-Bacchi V, Moulton EA, Kavanagh D, Dragon-Durey MA, Blouin J, et al. (2006) Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical haemolytic uremic syndrome. J Am Soc Nephrol 17: 2017–2025.
[5]
Zipfel PF, Jokiranta TS, Hellwage J, Koistinen V, Meri S (1999) The factor H protein family. Immunopharmacology 42: 53–60.
[6]
Diaz-Guillen MA, Rodriguez de Cordoba S, Heine-Suner D (1999) A radiation hybrid map of complement factor H and factor H-related genes. Immunogenetics 49: 549–552.
[7]
Male DA, Ormsby RJ, Ranganathan S, Giannakis E, Gordon C, et al. (2000) Complement factor H: Sequence analysis of 221 kb of human genomic DNA containing the entire fH, fHR-1 and fHR-3 genes. Mol Immunol 37: 41–52.
[8]
Warwicker P, Goodship THJ, Donne RL, Pirson Y, Nicholls A, et al. (1998) Genetic studies into inherited and sporadic haemolytic uremic syndrome. Kidney Int 53: 836–844.
[9]
Heinen S, Sanchez-Corral P, Jackson MS, Strain L, Goodship JA, et al. (2006) De novo gene conversion in the RCA cluster (1q32) causes mutations in complement factor H associated with atypical haemolytic uremic syndrome. Hum Mutat 27: 292–293.
[10]
Lupsky JR, Stankiewicz P (2005) Genomic disorders: Molecular mechanisms for rearrangements and conveyed phenotypes. PLoS Genet 1: e49.
[11]
Venables JP, Strain L, Routledge D, Bourn D, Powell HM, et al. (2006) Atypical haemolytic uraemic syndrome associated with a hybrid complement gene. PLoS Med 3: e431. DOI: 10.1371/journal.pmed.0030431.
[12]
Bresin E, Daina E, Noris M, Castelleti F, Stefanov R, et al. (2006) Outcome of renal transplantation in patients with non-shiga toxin-associated hemolytic uremic syndrome: Prognostic significance of genetic background. Clin J Am Soc Nephrol 1: 88–99.
